Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Fedro A. Peccatori,Hatem A. Azim,Roberto Orecchia,Harald J. Hoekstra,Nicholas Pavlidis,V. Kesic,George Pentheroudakis +6 more
Reads0
Chats0
TLDR
The aim of this work is to provide a systematic review and meta-analysis of the literature on canine coronavirus infection and its role in infertility and procreation that has been reported on in previous studies and is concerned with the well-being of newborns.About:
This article is published in Annals of Oncology.The article was published on 2013-10-01 and is currently open access. It has received 598 citations till now.read more
Citations
More filters
Book ChapterDOI
Special Issues in the Young and Pregnant Patient with Breast Cancer
Hatem A. Azim,Fedro A. Peccatori +1 more
TL;DR: The chapter discusses counselling of a patient who became accidentally pregnant on maintenance therapy with trastuzumab or tamoxifen and examines the options that could be offered to preserve fertility.
Journal ArticleDOI
Carcinoma in Pregnancy: What is the Impact on Fetus?
Journal ArticleDOI
Anticancer Agent Gefitinib and Congenital Anomalies
TL;DR: In this article, the authors reported the first case of multiple anomalies associated with antenatal exposure to the anticancer agent Gefitinib for stage IV adenocarcinoma of lungs.
Journal ArticleDOI
History of malignant neoplasia lessens oocyte developmental competence: a case-control study
Yuichi Jinno,Hisako Tobai,Shiori Imai,Miho Omura,Makoto Takeuchi,Mitsuyo Yoshida,Noriko Yano,M. Goto,Takahide Arimoto +8 more
TL;DR: A woman's history of malignant neoplasia was associated with decreased oocyte developmental competence, possibly related to patient's background factors predisposing to tumor.
Journal ArticleDOI
Survey for molecular reports in practicing oncologists in India
TL;DR: There is an increasing perception of the need for training in molecular oncology in India, according to an online survey of oncologists, which reflects a reality, in which specific needs are perceived.
References
More filters
Journal ArticleDOI
Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
Joseph A. Sparano,Joseph A. Sparano,Molin Wang,Silvana Martino,Vicky Jones,Edith A. Perez,Tom Saphner,Antonio C. Wolff,George W. Sledge,William C. Wood,Nancy E. Davidson +10 more
TL;DR: In this paper, the efficacy of two different taxanes, docetaxel and paclitaxel, given either weekly or every 3 weeks, in the adjuvant treatment of breast cancer was compared.
Journal ArticleDOI
Fertility Preservation in Breast Cancer Patients: A Prospective Controlled Comparison of Ovarian Stimulation With Tamoxifen and Letrozole for Embryo Cryopreservation
TL;DR: The combination of low-dose FSH with tamoxifen (TamFSH-IVF) or letrozole (Letrozoles- IVF) results in higher embryo yield compared with Tam-IVf, and the letroZole protocol may be preferred because it results in lower peak E2 levels.
Journal Article
Delayed childbearing: more women are having their first child later in life
T J Matthews,Brady E Hamilton +1 more
TL;DR: The age of the mother plays a strong role in a wide range of birth outcomes (e.g., birthweight, multiple births, and birth defects), so it is critical to track the average age at which women have their first birth.
Journal ArticleDOI
Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study.
TL;DR: The diagnosis of most cancer types during pregnancy or lactation does not increase the risk of cause-specific death, and the "healthy mother effect" for women with a postcancer pregnancy is confirmed.
Journal ArticleDOI
Safety of Fertility Preservation by Ovarian Stimulation With Letrozole and Gonadotropins in Patients With Breast Cancer: A Prospective Controlled Study
TL;DR: Ovarian stimulation with gonadotropins and letrozole for the purpose of fertility preservation is unlikely to cause substantially increased recurrence risk, and longer-term follow-up is needed to confirm these findings.
Related Papers (5)
Cancer and fertility preservation: international recommendations from an expert meeting
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
Halle C. F. Moore,Joseph M. Unger,Kelly-Anne Phillips,Frances M. Boyle,Frances M. Boyle,Erika Hitre,David L. Porter,Prudence A. Francis,Lori J. Goldstein,Henry L. Gomez,Carlos S. Vallejos,Ann H. Partridge,Shaker R. Dakhil,Agustin A. Garcia,Julie R. Gralow,Janine M. Lombard,John F. Forbes,Silvana Martino,William E. Barlow,Carol J. Fabian,Lori M. Minasian,Frank L. Meyskens,Richard D. Gelber,Gabriel N. Hortobagyi,Kathy S. Albain +24 more